Acción BMY BRISTOL-MYERS SQUIBB COMPANY
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Empresa Bristol-Myers Squibb Company

Acciones

BMY

US1101221083

Farmacéuticos

Tiempo real estimado Cboe BZX
Otros sitios de cotización
 18:31:10 19/04/2024 		Varia. Cinco días. Varia. 1 de enero.
48,56 USD +0,55 % Gráfico intradía de Bristol-Myers Squibb Company +0,58 % -5,36 %
18/04 BRISTOL-MYERS SQUIBB COMPANY : Wells Fargo Securities da una recomendación neutral ZM
15/04 BRISTOL-MYERS SQUIBB COMPANY : recomendación de compra de Wolfe Research ZM

Resumen de negocios

Bristol-Myers Squibb Company está especializada en el desarrollo, la fabricación y la comercialización de productos farmacéuticos. Los productos están destinados al tratamiento del cáncer, las enfermedades cardiovasculares, la hepatitis, las enfermedades inmunitarias y los trastornos psiquiátricos.
Estados Unidos representa el 70,1% de las ventas netas.

Número de empleados: 34 100

Ventas por actividad

USD en millones2022Peso2023Peso Delta
Innovative Medicines
100,0 %
46 159 100,0 % 45 006 100,0 % -2,50 %

Ventas por región

USD en millones2022Peso2023Peso Delta
United States
70,1 %
31 828 69,0 % 31 555 70,1 % -0,86 %
International
28,3 %
13 497 29,2 % 12 752 28,3 % -5,52 %
Other
1,6 %
834 1,8 % 699 1,6 % -16,19 %

Directores

Directores PuestoEdadDesde
Christopher Boerner CEO
 Chief Executive Officer 53 01/02/15
David Elkins DFI
 Director of Finance/CFO 55 20/11/19
Greg Meyers CTO
 Chief Tech/Sci/R&D Officer - -
Kimberly McCutcheon Jablonski CMP
 Compliance Officer - 01/01/03
Estelle Vester-Blokland CTO
 Chief Tech/Sci/R&D Officer - -
Samit Hirawat CTO
 Chief Tech/Sci/R&D Officer 55 01/01/19
Robert Plenge CTO
 Chief Tech/Sci/R&D Officer 53 01/11/19
Laura Hortas IRO
 Public Communications Contact - -
Cynthia Piccirillo PRN
 Corporate Officer/Principal - -
Cari Gallman PRN
 Corporate Officer/Principal - -

Administradores

Administradores PuestoEdadDesde
Phyllis Yale BRD
 Director/Board Member 66 20/11/19
Peter Arduini BRD
 Director/Board Member 59 01/04/16
Derica Rice BRD
 Director/Board Member 59 01/09/20
Paula Price BRD
 Director/Board Member 62 01/09/20
Gerald Storch BRD
 Director/Board Member 67 24/01/12
Theodore Samuels BRD
 Director/Board Member 69 21/02/17
David Elkins DFI
 Director of Finance/CFO 55 20/11/19
Christopher Boerner CEO
 Chief Executive Officer 53 01/02/15
Julia Haller BRD
 Director/Board Member 69 20/11/19
Manuel Hidalgo Medina BRD
 Director/Board Member 56 01/06/21

Clase de acciones

VoteQuantityFlotanteAutocontrolTotal Float
Acción A 1 2 928 758 715 2 024 582 731 ( 69,13 %) 902 000 000 ( 30,80 %) 69,13 %

Accionistas

NombreAcciones%Valoración
Vanguard Fiduciary Trust Co.
9,799 %
198 159 772 9,799 % 10 746 M $
BlackRock Advisors LLC
6,437 %
130 159 802 6,437 % 7 059 M $
JPMorgan Investment Management, Inc.
4,436 %
89 694 867 4,436 % 4 864 M $
STATE STREET CORPORATION
4,423 %
89 446 206 4,423 % 4 851 M $
Capital Research & Management Co. (International Investors)
3,043 %
61 528 492 3,043 % 3 337 M $
Fidelity Management & Research Co. LLC
2,107 %
42 604 966 2,107 % 2 310 M $
Geode Capital Management LLC
1,962 %
39 677 105 1,962 % 2 152 M $
BlackRock Life Ltd.
1,596 %
32 274 031 1,596 % 1 750 M $
Norges Bank (13F)
1,504 %
30 413 639 1,504 % 1 649 M $
Eaton Vance Management
1,452 %
29 362 744 1,452 % 1 592 M $
NombreAcciones%Valoración
Bram Bradesco Asset Management S/A DTVM
0,000243 %
4 921 0,000243 % 256 847 $
NombreAcciones%Valoración
Transcend Wealth Collective LLC
-
117 775 - 6 478 $
FourWorld Capital Management LLC
-
100 000 - 5 500 $
Davenport & Co. LLC
-
83 970 - 4 618 $
FIFTH THIRD BANCORP
-
20 000 - 1 100 $
Private Advisor Group LLC
-
15 000 - 825 $
Paradigm Financial Partners LLC
-
10 000 - 550 $
Northwestern Mutual Wealth Management Co.
-
242 - 13 $
OAKWORTH CAPITAL INC.
-
125 - 7 $

Participaciones

NombreAcciones%Valoración
AVIDITY BIOSCIENCES, INC.
6.37%
 5 075 304 6.37% 129 521 758 $
KURA ONCOLOGY, INC.
1.80%
 1 370 171 1.80% 29 225 747 $
UNIQURE N.V.
4.99%
 2 388 108 4.99% 12 418 162 $
COMPUGEN LTD.
5.31%
 4 757 058 5.31% 12 273 210 $
CELULARITY INC.
5.49%
 1 195 327 5.49% 6 251 560 $

Información de la empresa

Bristol Myers Squibb Co.

Route 206 & Province Line Road

08543, Princeton

+609 252 4621

http://www.bms.com
Dirección Bristol-Myers Squibb Company(BMY)

Empresas del grupo

NombreCategoría y sector
Bristol-Myers Squibb Pharmaceuticals Ltd.
Logo Bristol-Myers Squibb Pharmaceuticals Ltd.

Bristol-Myers Squibb Pharmaceuticals Ltd.

Pharmaceuticals: MajorHealth Technology

Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK.

Pharmaceuticals: Major
Celgene Alpine Investment Co. LLC
Bristol-Myers Squibb SARL
Logo Bristol-Myers Squibb SARL

Bristol-Myers Squibb SARL

Medical DistributorsDistribution Services

Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France.

Medical Distributors
Bristol-Myers Squibb Holdings Ireland Unlimited Co.
Logo Bristol-Myers Squibb Holdings Ireland Unlimited Co.

Bristol-Myers Squibb Holdings Ireland Unlimited Co.

Pharmaceuticals: MajorHealth Technology

Bristol-Myers Squibb Holdings Ireland Unlimited Co., a subsidiary of Bristol Myers Squibb Co., is a company headquartered in Ireland that operates as a holding company which develops medicines for serious diseases.

Pharmaceuticals: Major
Bristol-Myers Squibb Australia Pty Ltd.
Logo Bristol-Myers Squibb Australia Pty Ltd.

Bristol-Myers Squibb Australia Pty Ltd.

Pharmaceuticals: MajorHealth Technology

Bristol-Myers Squibb Australia Pty Ltd. is a biopharmaceutical company that researches, develops and markets medicines for serious diseases. The company was founded in 1930 and is headquartered in Noble Park North, Australia.

Pharmaceuticals: Major
Bristol-Myers Squibb (Finland) Oy Ab
Logo Bristol-Myers Squibb (Finland) Oy Ab

Bristol-Myers Squibb (Finland) Oy Ab

Pharmaceuticals: GenericHealth Technology

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb (Finland) Oy Ab is a Finnish pharmaceutical manufacturing company. The private company is based in Vantaa, Finland. The company was founded in 1974. Simone Böhrer has been the CEO of the company since 2020.

Pharmaceuticals: Generic
Bristol-Myers Squibb Belgium SA
Logo Bristol-Myers Squibb Belgium SA

Bristol-Myers Squibb Belgium SA

Pharmaceuticals: MajorHealth Technology

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The private company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante.

Pharmaceuticals: Major
Bristol-Myers Squibb de México S de RL de CV
Logo Bristol-Myers Squibb de México S de RL de CV

Bristol-Myers Squibb de México S de RL de CV

Pharmaceuticals: MajorHealth Technology

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The private company is located in Mexico.

Pharmaceuticals: Major
Bristol-Myers Squibb AB
Logo Bristol-Myers Squibb AB

Bristol-Myers Squibb AB

Medical DistributorsDistribution Services

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb AB is a private company that wholesales medical equipment and pharmacy. The company is based in Solna, Sweden.

Medical Distributors

Sector

Salud
Farmacéutica e investigación médica
Farmacéuticos
Farmacéuticos
Farmacéuticos - Otros

Ventas por región

Notaciones para Bristol-Myers Squibb Company

Calificación trading
Calificación Inversor
ESG Refinitiv
B
Más Ratings

Consenso de los analistas

Venta
Consenso
Compra
Recomendación promedio
CONSERVAR
Numero de análisis
27
Último precio de cierre
48,3 USD
Precio objetivo promedio
56,33 USD
Diferencia / Objetivo Promedio
+16,62 %
Consenso

Revisiones del BPA

Revisiones de las previsiones

Beneficios trimestrales - Tasa de sorpresa

La agenda de la empresa

Sector Farmacéuticos - Otros

Varia. 1 de ene. Capi.
BRISTOL-MYERS SQUIBB COMPANY Acción Bristol-Myers Squibb Company
-5,36 % 97,89 mil M
ELI LILLY AND COMPANY Acción Eli Lilly and Company
+25,26 % 672 mil M
NOVO NORDISK A/S Acción Novo Nordisk A/S
+24,08 % 550 mil M
JOHNSON & JOHNSON Acción Johnson & Johnson
-6,38 % 351 mil M
MERCK & CO., INC. Acción Merck & Co., Inc.
+15,12 % 317 mil M
ABBVIE INC. Acción AbbVie Inc.
+7,30 % 292 mil M
ASTRAZENECA PLC Acción AstraZeneca PLC
+3,26 % 211 mil M
NOVARTIS AG Acción Novartis AG
+0,78 % 203 mil M
PFIZER, INC. Acción Pfizer, Inc.
-10,33 % 144 mil M
AMGEN INC. Acción Amgen Inc.
-7,35 % 141 mil M
Farmacéuticos - Otros
  1. Bolsa de valores
  2. Acciones
  3. Acción BMY
  4. Empresa Bristol-Myers Squibb Company